Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$2.74 - $6.25 $43,727 - $99,743
15,959 New
15,959 $47.2 Million
Q4 2022

Feb 14, 2023

BUY
$3.23 - $5.64 $51,402 - $89,754
15,914 New
15,914 $89,000
Q3 2022

Nov 14, 2022

SELL
$3.34 - $9.2 $54,892 - $151,202
-16,435 Reduced 50.75%
15,949 $53,000
Q2 2022

Aug 15, 2022

SELL
$6.39 - $16.24 $26,071 - $66,259
-4,080 Reduced 11.19%
32,384 $272,000
Q1 2022

May 11, 2022

SELL
$12.79 - $21.64 $62,811 - $106,274
-4,911 Reduced 11.87%
36,464 $504,000
Q4 2021

Feb 11, 2022

SELL
$17.49 - $26.72 $44,791 - $68,429
-2,561 Reduced 5.83%
41,375 $847,000
Q3 2021

Nov 12, 2021

BUY
$17.47 - $27.49 $767,561 - $1.21 Million
43,936 New
43,936 $1.09 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $247M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.